ONCXERNA THERAPEUTICS
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform. OncXerna Therapeutics is aiming to deliver next-generation precision medicine for a larger group of cancer patients by leveraging the company’s deep understanding of how to prospectively identify patients based on the dominant biology of their tumor microenvironments. This allows OncXerna to pair those patients with OncXerna’s clinical-stage therapies with known mechanisms of action that directly address these biologies, to dramatically improve patient outcomes. The company was founded in 2018 and was formerly known as Oncologie.
ONCXERNA THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical Device Pharmaceutical
Founded:
2018-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.oncxerna.com
Total Employee:
11+
Status:
Active
Contact:
(781) 907 - 7810
Total Funding:
126.5 M USD
Technology used in webpage:
SPF Content Delivery Network Microsoft Exchange Online Office 365 Mail IPv6 Cloudflare Hosting JQuery CDN Cloudflare DNS Visual Composer Ultimate Addons OneTrust
Similar Organizations
BlossomHill Therapeutics
BlossomHill Therapeutics, Inc. is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Osteal Therapeutics
Osteal Therapeutics is a clinical stage specialty pharmaceutical company developing novel treatments for orthopedic infections.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Omega Therapeutics
Omega Therapeutics offers a proprietary epigenomic programming platform.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Employees Featured
Founder
Investors List
Pivotal bioVenture Partners China
Pivotal bioVenture Partners China investment in Series B - OncXerna Therapeutics
Korea Investment Partners
Korea Investment Partners investment in Series B - OncXerna Therapeutics
Panacea Venture
Panacea Venture investment in Series B - OncXerna Therapeutics
Nan Fung Life Sciences
Nan Fung Life Sciences investment in Series B - OncXerna Therapeutics
Pivotal bioVenture Partners China
Pivotal bioVenture Partners China investment in Seed Round - OncXerna Therapeutics
CMB International Capital Corporation
CMB International Capital Corporation investment in Seed Round - OncXerna Therapeutics
Nan Fung Life Sciences
Nan Fung Life Sciences investment in Seed Round - OncXerna Therapeutics
Volcanics Venture
Volcanics Venture investment in Seed Round - OncXerna Therapeutics
Official Site Inspections
http://www.oncxerna.com Semrush global rank: 5.11 M Semrush visits lastest month: 1.6 K
- Host name: 172.66.43.49
- IP address: 172.66.43.49
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
